Advertisement
Review Article| Volume 102, ISSUE 3, P335-344, June 2022

Lung Cancer

Epidemiology and Screening
Published:April 21, 2022DOI:https://doi.org/10.1016/j.suc.2021.12.001

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Surgical Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Siegel R.L.
        • Miller K.D.
        • Fuchs H.E.
        • et al.
        Cancer Statistics, 2021.
        CA Cancer J Clin. 2021; 71 ([Erratum appears in CA Cancer J Clin 202171(4):359]): 7-33
      1. Howlader N. Noone A.M. Krapcho M. SEER Cancer Statistics Review, 1975-2018. National Cancer Institute, Bethesda (MD)2021 (Available at:)
        • Ferlay J.
        • Colombet M.
        • Soerjomataram I.
        • et al.
        Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.
        Int J Cancer. 2019; 144: 1941-1953
        • Alberg A.J.
        • Brock M.V.
        • Ford J.G.
        • et al.
        Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
        Chest. 2013; 143: e1S-e29S
        • Jackson S.S.
        • Han X.
        • Mao Z.
        • et al.
        Cancer Stage, Treatment, and Survival Among Transgender Patients in the United States.
        J Natl Cancer Inst. 2021; 113: 1221-1227
        • Concannon K.F.
        • Thayer J.H.
        • Wu Q.V.
        • et al.
        Outcomes among homeless patients with non-small-cell lung cancer: a county hospital experience.
        JCO Oncol Pract. 2020; 16: e1004-e1014
        • Bergamo C.
        • Sigel K.
        • Mhango G.
        • et al.
        Inequalities in lung cancer care of elderly patients with schizophrenia: an observational cohort study.
        Psychosom Med. 2014; 76: 215-220
        • Aziz H.
        • Ackah R.L.
        • Whitson A.
        • et al.
        Cancer care in the incarcerated population: barriers to quality care and opportunities for improvement.
        JAMA Surg. 2021; 156: 964-973
        • Cornelius M.E.
        • Wang T.W.
        • Jamal A.
        • et al.
        Tobacco Product Use Among Adults – United States, 2019.
        Morbidity Mortality Weekly Rep. 2020; 69 (Available at:) (Accessed November 19, 2020): 1736-1742
        • Zhang L.R.
        • Morgenstern H.
        • Greenland S.
        • et al.
        • Cannabis and Respiratory Disease Research Group of New Zealand, Brhane Y, Liu G, Hung RJ
        Cannabis smoking and lung cancer risk: pooled analysis in the International Lung Cancer Consortium.
        Int J Cancer. 2015; 136: 894-903
        • Jett J.
        • Stone E.
        • Warren G.
        • et al.
        Cannabis Use, Lung Cancer, and Related Issues.
        J Thorac Oncol. 2018; 13: 480-487
        • Choi H.
        • Mazzone P.
        Radon and lung cancer: assessing and mitigating the risk.
        Cleve Clin J Med. 2014; 81: 567-575
        • Krewski D.
        • Lubin J.H.
        • Zielinski J.M.
        • et al.
        A combined analysis of North American case-control studies of residential radon and lung cancer.
        J Toxicol Environ Health A. 2006; 69: 533-597
        • Lubin J.H.
        • Boice Jr., J.D.
        • Edling C.
        • et al.
        Lung cancer in radon-exposed miners and estimation of risk from indoor exposure.
        J Natl Cancer Inst. 1995; 87: 817-827
        • Klebe S.
        • Leigh J.
        • Henderson D.W.
        • et al.
        Asbestos, smoking and lung cancer: an update.
        Int J Environ Res Public Health. 2019; 17: 258
        • Allen L.P.
        • Baez J.
        • Stern M.E.C.
        • et al.
        Trends and the economic effect of asbestos bans and decline in asbestos consumption and production worldwide.
        Int J Environ Res Public Health. 2018; 15: 531
        • Gotts J.E.
        • Jordt S.E.
        • McConnell R.
        • et al.
        What are the respiratory effects of e-cigarettes?.
        BMJ. 2019; 366 ([Erratum appears in BMJ 2019;367:l5980]): l5275
        • Aberle D.R.
        • Adams A.M.
        • Berg C.D.
        • et al.
        • National Lung Screening Trial Research Team
        Reduced lung-cancer mortality with low-dose computed tomographic screening.
        N Engl J Med. 2011; 365: 395-409
        • National Lung Screening Trial Research Team
        Lung cancer incidence and mortality with extended follow-up in the national lung screening trial.
        J Thorac Oncol. 2019; 14: 1732-1742
        • de Koning H.J.
        • van der Aalst C.M.
        • de Jong P.A.
        • et al.
        Reduced lung-cancer mortality with volume ct screening in a randomized trial.
        N Engl J Med. 2020; 382: 503-513
        • Moyer V.A.
        • U.S. Preventive Services Task Force
        Screening for lung cancer: U.S. preventive services task force recommendation statement.
        Ann Intern Med. 2014; 160: 330-338
        • Krist A.H.
        • Davidson K.W.
        • Mangione C.M.
        • et al.
        • US Preventive Services Task Force
        Screening for lung cancer: US preventive services task force recommendation statement.
        JAMA. 2021; 325: 962-970
        • Stowell J.T.
        • Parikh Y.
        • Tilson K.
        • et al.
        Lung cancer screening eligibility and utilization among transgender patients: an analysis of the 2017-2018 United States Behavioral Risk Factor Surveillance System Survey.
        Nicotine Tob Res. 2020; 22: 2164-2169
        • Landy R.
        • Young C.D.
        • Skarzynski M.
        • et al.
        Using Prediction-Models to Reduce Persistent Racial/Ethnic Disparities in Draft 2020 USPSTF Lung-Cancer Screening Guidelines.
        J Natl Cancer Inst. 2021; : djaa211https://doi.org/10.1093/jnci/djaa211
        • Zahnd W.E.
        • Eberth J.M.
        Lung cancer screening utilization: a behavioral risk factor surveillance system analysis.
        Am J Prev Med. 2019; 57: 250-255
        • Narayan A.K.
        • Gupta Y.
        • Little B.P.
        • et al.
        Lung cancer screening eligibility and use with low-dose computed tomography: Results from the 2018 Behavioral Risk Factor Surveillance System cross-sectional survey.
        Cancer. 2021; 127: 748-756
        • Kan C.F.K.
        • Unis G.D.
        • Li L.Z.
        • et al.
        Circulating Biomarkers for Early Stage Non-Small Cell Lung Carcinoma Detection: Supplementation to Low-Dose Computed Tomography.
        Front Oncol. 2021; 11: 555331